← Back to Clinical Trials
Recruiting NCT07423195

NCT07423195 Impact of Cannabis Use During Third Molar Surgery

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT07423195
Status Recruiting
Phase
Sponsor University of Michigan
Condition Cannabis Use
Study Type OBSERVATIONAL
Enrollment 242 participants
Start Date 2026-01-14
Primary Completion 2029-01

Eligibility & Interventions

Sex All sexes
Min Age 16 Years
Max Age 99 Years
Study Type OBSERVATIONAL

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.

This trial targets 242 participants in total. It began in 2026-01-14 with a primary completion date of 2029-01.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

This study is for people scheduled to have their wisdom teeth (third molars) removed and are going to receive drug through an IV to put them to sleep. The researchers are studying two groups: one group of people who report using recreational marijuana/THC/cannabis and another group who report not using it. They want to look at how both users and non-users do during the tooth removal.

Eligibility Criteria

Inclusion Criteria: * Provide a signed and dated informed consent form. * Willing to comply with all study procedures and be available for the duration of the study. * Aged ≥ 16 years old. * Presence at least one mandibular 3rd molar * American Society of Anesthesiologists (ASA) physical status class I or II Exclusion Criteria: * Pathology (cyst or tumor) associated with the third molar tooth; * Health comorbidities (BMI 40 and above, and severe cardiovascular disease); * Pregnancy or lactation * Anything that would place the individual at increased risk or preclude the individual's full compliance with or completion of the study.

Contact & Investigator

Central Contact

Jennifer A Lay-Luskin, MPhil, CCRC

✉ jalay@umich.edu

📞 Oral and Maxillofacial Surgery

Principal Investigator

Paulo zupelari Gonclaves, DDS, MS, PhD

PRINCIPAL INVESTIGATOR

University of Michigan School of Dentistry/Oral and Maxillofacial Surgery/Hospital Dentistry

Frequently Asked Questions

Who can join the NCT07423195 clinical trial?

This trial is open to participants of all sexes, aged 16 Years or older, up to 99 Years, studying Cannabis Use. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT07423195 currently recruiting?

Yes, NCT07423195 is actively recruiting participants. Contact the research team at jalay@umich.edu for enrollment information.

Where is the NCT07423195 trial being conducted?

This trial is being conducted at Ann Arbor, United States.

Who is sponsoring the NCT07423195 clinical trial?

NCT07423195 is sponsored by University of Michigan. The principal investigator is Paulo zupelari Gonclaves, DDS, MS, PhD at University of Michigan School of Dentistry/Oral and Maxillofacial Surgery/Hospital Dentistry. The trial plans to enroll 242 participants.

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology